November 2024
Strategy

Big wheels keep on turnin’
The US election throws up several investment ideas from the mainstream to the more idiosyncratic...
20 Nov
20 Nov
Strategy

The Asset Allocators: Is America still the land of investment opportunity?
The experts tell us the areas they like and dislike…
17 Nov
17 Nov
Bull vs bear

Bull vs bear: Bellevue Healthcare
We provide a round-up of the bull and bear arguments for Bellevue Healthcare...
21 Nov
21 Nov
Trust issues

Trust Issues - investing in biotech with IBT managers Ailsa Craig & Marek Poszepczynski
We discuss opportunities for investors in the biotech sector with the managers of IBT...
11 Nov
11 Nov
Trust issues

Trust Issues: the future of weight-loss drugs with BBH portfolio manager Paul Major
Paul Major talks us through BBH’s exposure to weight-loss drugs…
04 Nov
04 Nov
Features

How will the US election impact biotechnology?
How the biotech sector may fare in different election outcomes...
01 Nov
01 Nov
News

Results analysis: International Biotechnology Trust
IBT continues to outperform its index, showcasing the benefits of active management…
05 Nov
05 Nov
Fund Research

International Biotechnology
IBT’s managers are positioned for the sector’s recovery to continue…
13 Nov
13 Nov
September 2024
Features

Changing of the guard
BBH’s combination of offensive and defensive qualities looks attractive…
23 Sep
23 Sep
Features

Green green grass
Why the biotech sector is bouncing back to rude health…
19 Sep
19 Sep
Fund Research

Bellevue Healthcare
BBH looks set for a recovery as interest rates fall…
26 Sep
26 Sep
August 2024
Strategy

Dream team
Our analysts review how their fund picks for 2024 have done…
28 Aug
28 Aug
Blog

Don’t look back in anger
US equities are worth rolling with, but the market is broadening…
31 Aug
31 Aug
Trusts in focus

Trusts in Focus: Bellevue Healthcare
We give you the lowdown on healthcare specialist BBH...
06 Aug
06 Aug
July 2024
Strategy

A really great stockmarket, the best, some tell me the best they’ve ever seen
US equities should be the bedrock of any diversified portfolio…
03 Jul
03 Jul
Blog

Ch-ch-ch-changes
Politics isn’t the only place where there are big changes at the top, but for shareholders change is often a good thing…
13 Jul
13 Jul
March 2024
Strategy

How to grow old gracefully (and preferably rich)...
Ahead of the final week of our event, focused on retirement planning, we consider some of the complexities of portfolio construction…
20 Mar
20 Mar
Strategy

Roller coaster ride
Thematic funds have seen significant outflows over the past two years…
13 Mar
13 Mar
Blog

Healthcare, UK valuations, and renewables
We take a look back at the final week of our ISA event…
28 Mar
28 Mar
Blog

Trend setters
We take a look at four mega-trends to future-proof your portfolio…
22 Mar
22 Mar
Features

Bouncing back to rude health
IBT is well-positioned to exploit the attractive valuations on offer in the biotech sector…
06 Mar
06 Mar
Features

Behind the trust: International Biotechnology Trust plc
Biotech companies stand to inject high returns and positive social impact into an investor’s portfolio and International Biotechnology Trust has an impressive track record of doing this with lower volatility than the index (NASDAQ Biotechnology Index), while paying a healthy dividend yield...
01 Mar
01 Mar
News

Results analysis: Bellevue Healthcare
Reviewing a tough financial year, but the last three months give grounds for optimism...
05 Mar
05 Mar
Fund Research

Bellevue Healthcare
BBH could be poised for strong performance as the rate cycle eases…
21 Mar
21 Mar
February 2024
Guides

Investing in biotechnology with investment trusts
How investment trusts can provide investors with access to the high-growth biotech sector…
27 Feb
27 Feb
Video

Talking Trusts: An introduction to investing in biotech with International Biotechnology Trust
We talk about what IBT offers for investors looking for exposure to the biotech sector…
27 Feb
27 Feb
Features

Waiting for the world to change
Closed-ended trusts are a simple way to access the attractive income and defensive potential of renewables infrastructure…
20 Feb
20 Feb